Close menu




Agriculture

Photo credits: pixabay.com

Commented by Nico Popp on March 16th, 2026 | 07:25 CET

Energy Crisis Drives Agricultural Transformation: Opportunities in MustGrow Biologics, K+S, and Corteva Agriscience

  • biologics
  • agritech
  • Agriculture
  • fertilizer
  • geopolitics

Agriculture is at a turning point. The reason is the renewed escalation in the Middle East. The Strait of Hormuz, through which roughly one-fifth of global liquefied natural gas shipments and significant volumes of fertilizer-related trade pass, represents one of the world's most critical energy chokepoints. The resulting instability has pushed energy prices higher and stalled the production of synthetic nitrogen fertilizers. Since natural gas is the base raw material for fertilizer production, agricultural companies and farmers must rethink their strategies. In this environment, agricultural innovation will play a crucial role in securing future food supply. Companies such as K+S and Corteva Agriscience are responding to cost pressures in energy raw materials, while MustGrow Biologics is attracting attention with biological solutions that could reduce reliance on synthetic fertilizers.

Read

Commented by Armin Schulz on March 11th, 2026 | 07:20 CET

Three trends, one goal: How Bayer, MustGrow Biologics, and BASF are turning the agricultural revolution into a profit opportunity

  • Agritech
  • Sustainability
  • mustard
  • Agriculture
  • chemicals
  • fertilizer

Three trends are currently driving the global agricultural economy: skyrocketing fertilizer prices, regulatory pressure to preserve biodiversity, and the insatiable hunger of a growing population. As farmers navigate between existential fears and the pressure to go green, a billion-dollar transformation of industry is looming. Old chemistry is reaching its limits, while demand for biological alternatives and precision technologies is reaching an all-time high. Amid this tension between volatility and opportunity, the future of plant production is being reshaped. We take a look at how Bayer, MustGrow Biologics, and BASF are driving this transformation and could benefit from it.

Read

Commented by Fabian Lorenz on March 6th, 2026 | 07:20 CET

SHORT SQUEEZE at Gerresheimer? Will Bayer and MustGrow soon grow together?

  • Agritech
  • Agriculture
  • packaging
  • shortsqueeze

While the stock market digests the Iran war and rising energy prices, Gerresheimer's share price is suddenly rising noticeably. There is no news. Is a short squeeze possible? Short sellers had even expanded their positions recently. Bayer does not (yet) hold a stake in MustGrow. However, the Leverkusen-based company has acquired a license to distribute the innovative agricultural products and is investing in their approval. This could enable MustGrow shares to make the leap from hidden gem to high flyer. Management has recently expressed optimism. The stock appears to be undervalued. After the sharp setback in recent weeks, analysts see upside potential for Bayer again. However, shareholders should not expect much in terms of revenue and profit growth in the current year. Cash flow is even expected to be significantly negative.

Read

Commented by Armin Schulz on February 24th, 2026 | 07:15 CET

MustGrow Biologics and its partnership with Bayer: Why the stock is only just getting started

  • Agriculture
  • Sustainability
  • biologics
  • agritech

Global agriculture is facing a paradox. It needs to feed more people, but with fewer chemical inputs. Worldwide, 460 pesticides are now banned or restricted across 162 countries. The era of synthetic active ingredients is coming to an end – but what comes next? A Canadian company believes it has found the answer. It grows in the field, is spicy and yellow: mustard. MustGrow Biologics has developed a technology that uses the natural defenses of the mustard plant to remediate soils and increase yields. What sounds like a niche idea could turn out to be one of the most exciting investments in the agricultural sector.

Read

Commented by Nico Popp on February 20th, 2026 | 07:25 CET

Agricultural revolution breaks the billion-dollar barrier: Why MustGrow Biologics, Bayer, and Bioceres Crop Solutions are ending the era of chemicals

  • biologics
  • Agriculture
  • agritech
  • Sustainability
  • Investments

The agricultural industry is currently transitioning from toxic chemicals to high-performance biologics. In this market environment, various players are positioning themselves with complementary strategies to capture the gigantic market for sustainable crop protection, which is expected to generate billions of dollars in revenue in the future. The ongoing deterioration of farmland and increasingly restrictive regulations are forcing farmers and corporations alike to rethink their approaches. It is no longer just about purely ecological ideals, but about food for humanity. Established agricultural giants and innovative technology companies are working feverishly to secure yields without further depleting nature. In this race, clear winners are emerging who are laying the foundation for the agriculture of the future and offering investors unprecedented opportunities. MustGrow Biologics is an exciting candidate.

Read

Commented by Fabian Lorenz on February 9th, 2026 | 07:30 CET

Bayer shares in the fast lane! Partner MustGrow Biologics facing revaluation!

  • Agritech
  • Sustainability
  • fertilizer
  • Agriculture

For Bayer, things are currently going extremely well. The group is bringing its problem areas under control while reporting tangible progress in its pharmaceutical business. In the shadow of this, the company has secured the license for a new biologically safe product platform for fertilizers. Its partner in this venture is MustGrow Biologics. The company is on the verge of transitioning from research to commercialization, with management planning a market launch later this year. Production capacities are already being expanded in Asia. Against this backdrop, MustGrow shares appear poised for a revaluation - and the company is increasingly emerging as a potential takeover candidate.

Read

Commented by Nico Popp on February 4th, 2026 | 07:05 CET

Solution to a billion-dollar problem: MustGrow Biologics validates business model – Revolutionary news also for Bayer and Corteva Agriscience

  • Agriculture
  • agritech
  • crops
  • Investments

Canola is to Canada what oil is to Saudi Arabia: an economic driver of enormous proportions. With an estimated production value of around CAD 14 billion in 2025, the yellow-flowering crop is the "green gold" of the prairie. Yet this billion-dollar market is in danger: clubroot, an aggressive soil-borne disease, threatens crops and is already causing annual losses exceeding CAD 500 million. Previous solutions have reached their biological limits, but now the Canadian AgriTech company MustGrow Biologics is reporting a decisive success. As the company announced on Tuesday, its proprietary TerraMG™ technology has not only suppressed the disease in large-scale field trials, but also significantly increased yields. For agricultural giants like Bayer and Corteva, this could be the decisive lever to protect their high-performance seed varieties over the long term.

Read

Commented by André Will-Laudien on January 26th, 2026 | 07:30 CET

Biotech and life sciences are booming, and now Mercosur is joining the fray! Bayer, MustGrow, Novo Nordisk, and BioNxt Solutions in focus

  • Biotechnology
  • Pharma
  • Agriculture
  • Biotech

The 2026 stock market year has a few surprises in store for investors. In addition to a quick resolution to the Greenland dispute, the Mercosur trade agreement with several South American countries is also moving forward. This agreement is particularly significant for the agricultural industry. This global sector of human supply is increasingly characterized by regulatory pressure, which is effectively ending the use of many synthetic pesticides and fertilizers. This development is forcing established agricultural companies to integrate effective biological alternatives into their portfolios faster than planned. In this environment, MustGrow Biologics is positioning itself as a strategic technology provider whose active ingredients have already been validated by leading market players. An expanded sector view also covers the life sciences industry with the protagonists Bayer, Novo Nordisk, and BioNxt. Up 50% in just a few weeks, here they are!

Read

Commented by Nico Popp on January 23rd, 2026 | 07:15 CET

Revolution in agricultural chemistry: How MustGrow Biologics is benefiting from the plight of Bayer and Corteva

  • Agriculture
  • Technology
  • Agriscience
  • Biotechnology

Global agriculture is at a historic turning point, driven less by a belief in technological progress than by regulatory necessity. For decades, global food security has been based on synthetic pesticides and fertilizers, but that era is rapidly coming to an end. Authorities from Brussels to California are tightening the screws and banning established active ingredients one after the other because their ecological collateral damage is no longer tolerated. For the agricultural giants, this poses an existential threat: their full warehouses are in danger of becoming worthless if they do not find effective biological alternatives quickly enough. In the current extremely hectic environment in industry, which is characterized by billion-dollar acquisitions and strategic alliances, new power structures are emerging. While Corteva Agriscience is aggressively buying market share with its chequebook and Bayer is pushing ahead with its portfolio restructuring, the Canadian company MustGrow Biologics has carved out a position that is considered the "sweet spot" in the industry. The Company is the technology partner whose active ingredients have already been validated and licensed by the market leaders.

Read

Commented by Armin Schulz on June 19th, 2025 | 07:10 CEST

Profit from Palantir? You can get in on the action with Argo Living Soils and D-Wave Quantum!

  • agritech
  • Agriculture
  • computing
  • Software
  • Technology

While AI and quantum computing have already experienced their first boom phases, an underestimated revolution is looming! High-performance materials are transforming our physical world. Graphene-optimized building materials not only increase the compressive strength of infrastructure by up to 30% and halve CO₂ emissions but also pave the way for "smart" roads and buildings. Those who recognized the opportunities offered by artificial intelligence early on were able to secure a rare opportunity. Quantum computing is still in its infancy but has already seen its first hype wave. The innovation of graphene materials is creating a new and unique opportunity for early investors. We take a look at Palantir, Argo Living Soils, and D-Wave Quantum as representative examples from each sector.

Read